Growing studies demonstrate that elevated circulating FABP4 levels correlate with an increased risk for obesity [24], type 2 diabetes [25], various cardiovascular diseases [26], and cancers [27] in a wide variety of populations. This evidence concerns the gene FABP4 and cardiovascular disorder.